MD Pediatrix Medical Group, Inc.
Services-Hospitals · NYSE · SEC CIK 893949 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY1.9%
TTM net income YoY-7.5%
TTM EPS YoY-4.2%
Revenue 3-yr CAGR-0.9%
Net income 3-yr CAGR17.1%
Margins
Gross margin—
Operating margin10.9%
Net margin7.7%
FCF margin—
EBITDA margin12.1%
Returns
ROE17.2%
ROA6.9%
ROIC (approx.)13.8%
Asset turnover0.90x
Leverage & solvency
Liabilities / assets60.3%
Debt / equity0.68x
Current ratio1.28x
Interest coverage6.38x
Cash quality & payout
Operating cash flow / net income1.51x
Accruals ratio-3.5%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $1.91B | $2.01B | $1.99B | $1.97B | $1.91B |
| SG&A expense | $240.79M | $238.44M | $227.54M | $231.40M | $263.36M |
| Operating income | $208.81M | -$68.71M | $7.32M | $172.69M | $202.92M |
| Interest expense | $35.97M | $40.74M | $42.08M | $39.70M | $68.72M |
| Pretax income | $216.43M | -$101.34M | -$48.36M | $81.37M | $135.23M |
| Income tax | $51.04M | -$2.27M | $12.05M | $18.81M | $27.24M |
| Net income | $165.39M | -$99.07M | -$60.41M | $66.33M | $130.96M |
| EBITDA | $230.64M | -$36.49M | $43.49M | $208.32M | $235.06M |
| EPS (basic) | 1.97 | -1.19 | -0.73 | 0.79 | 1.54 |
| EPS (diluted) | 1.94 | -1.19 | -0.73 | 0.79 | 1.53 |
| Weighted avg. shares (diluted) | 85.27M | 83.33M | 82.20M | 84.12M | 85.83M |
| Balance sheet | |||||
| Cash & equivalents | $375.24M | $229.94M | $73.26M | $9.82M | $387.39M |
| Short-term investments | $124.48M | $118.57M | $104.48M | $93.24M | $99.72M |
| Receivables | $229.66M | $259.99M | $272.31M | $296.79M | $301.77M |
| Current assets | $763.51M | $639.61M | $483.45M | $427.99M | $840.56M |
| PP&E, net | $39.18M | $39.17M | $75.64M | $73.29M | $70.15M |
| Goodwill | $1.26B | $1.24B | $1.38B | $1.53B | $1.51B |
| Intangibles | $16.86M | $11.60M | $21.24M | $18.49M | $21.57M |
| Total assets | $2.25B | $2.15B | $2.22B | $2.35B | $2.72B |
| Current liabilities | $458.91M | $434.11M | $388.95M | $426.98M | $427.37M |
| Short-term debt | $26.81M | $20.55M | $14.91M | $14.90M | $2.49M |
| Long-term debt | $570.53M | $597.12M | $618.42M | $632.38M | $989.70M |
| Total debt | $597.34M | $617.66M | $633.33M | $647.28M | $992.19M |
| Total liabilities | $1.38B | $1.39B | $1.37B | $1.46B | $1.83B |
| Shareholders' equity | $865.85M | $764.94M | $849.06M | $891.63M | $896.49M |
| Net debt | $222.10M | $387.72M | $560.08M | $637.46M | $604.80M |
| Shares outstanding | 82.98M | 85.87M | 84.02M | 82.95M | 86.42M |
| Cash flow statement | |||||
| Operating cash flow | $271.09M | $206.57M | $137.32M | $166.94M | $76.74M |
| Investing cash flow | -$18.30M | -$35.41M | -$48.18M | -$56.95M | -$53.07M |
| Financing cash flow | -$107.49M | -$14.48M | -$25.71M | -$487.55M | -$760.12M |
| Depreciation & amortization | $21.83M | $32.23M | $36.17M | $35.64M | $32.15M |
| Stock-based compensation | $18.05M | $11.87M | $12.32M | $16.13M | $18.97M |
| Share buybacks | $86.68M | $1.70M | $919,000 | $88.51M | $4.72M |
Free plan shows the latest 5 periods; Pro shows all 18 🔒
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.